NL8200022A - Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. - Google Patents
Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. Download PDFInfo
- Publication number
- NL8200022A NL8200022A NL8200022A NL8200022A NL8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A NL 8200022 A NL8200022 A NL 8200022A
- Authority
- NL
- Netherlands
- Prior art keywords
- carnitine
- butyrobetaine
- gamma
- patients
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT47518/81A IT1198434B (it) | 1981-01-06 | 1981-01-06 | Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina |
IT4751881 | 1981-01-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8200022A true NL8200022A (nl) | 1982-08-02 |
Family
ID=11260827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8200022A NL8200022A (nl) | 1981-01-06 | 1982-01-06 | Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4382092A (it) |
JP (1) | JPS57136516A (it) |
AU (1) | AU548787B2 (it) |
BE (1) | BE891639A (it) |
CH (1) | CH649218A5 (it) |
DE (1) | DE3200016A1 (it) |
FR (1) | FR2497510B1 (it) |
GB (1) | GB2091101B (it) |
GR (1) | GR75132B (it) |
IE (1) | IE52404B1 (it) |
IL (1) | IL64632A0 (it) |
IT (1) | IT1198434B (it) |
LU (1) | LU83869A1 (it) |
NL (1) | NL8200022A (it) |
SE (1) | SE453569B (it) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190280B (it) * | 1986-04-24 | 1988-02-16 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di gamma-butirrobetaina |
US5030458A (en) * | 1989-11-27 | 1991-07-09 | Shug Austin L | Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |
IT1219448B (it) * | 1988-02-12 | 1990-05-18 | Sigma Tau Ind Farmaceuti | Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina |
US5240961A (en) * | 1992-07-02 | 1993-08-31 | Shug Austin L | Method of treating reduced insulin-like growth factor and bone loss associated with aging |
US20030170290A1 (en) * | 1993-06-16 | 2003-09-11 | Shug Austin L. | Delayed release carnitine |
JP2553013B2 (ja) * | 1993-07-19 | 1996-11-13 | ヤマハ発動機株式会社 | 燃料噴射式エンジンの吸気装置 |
US5569457A (en) * | 1994-11-18 | 1996-10-29 | Shug; Austin L. | Method of stimulating antibody formation |
JP3119430B2 (ja) * | 1995-07-25 | 2000-12-18 | 大鵬薬品工業株式会社 | 水酸基ラジカル消去剤 |
LV11727B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
LV11728B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
AUPO821097A0 (en) * | 1997-07-25 | 1997-08-14 | Cultor Ltd. | A prophylactic |
KR100411275B1 (ko) * | 1999-09-15 | 2003-12-18 | 주식회사 포스코 | 언로더 코일 적치위치 제어장치 |
DE19956772A1 (de) * | 1999-11-25 | 2001-06-07 | Basf Ag | Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung |
US6476010B2 (en) | 2000-03-10 | 2002-11-05 | Hill's Pet Nutrition | Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
LV12978B (en) * | 2001-09-07 | 2003-05-20 | Ivars Kalvins | Pharmaceutical composition |
LV12979B (en) * | 2001-09-07 | 2003-05-20 | Ivars Kalvins | Pharmaceutical composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
-
1981
- 1981-01-06 IT IT47518/81A patent/IT1198434B/it active
- 1981-12-21 US US06/332,562 patent/US4382092A/en not_active Expired - Fee Related
- 1981-12-24 IL IL64632A patent/IL64632A0/xx not_active IP Right Cessation
- 1981-12-28 BE BE0/206948A patent/BE891639A/fr not_active IP Right Cessation
- 1981-12-30 AU AU79087/81A patent/AU548787B2/en not_active Ceased
- 1981-12-31 IE IE3099/81A patent/IE52404B1/en not_active IP Right Cessation
-
1982
- 1982-01-02 DE DE19823200016 patent/DE3200016A1/de active Granted
- 1982-01-04 SE SE8200007A patent/SE453569B/sv not_active IP Right Cessation
- 1982-01-04 GR GR66937A patent/GR75132B/el unknown
- 1982-01-04 GB GB8200054A patent/GB2091101B/en not_active Expired
- 1982-01-05 CH CH31/82A patent/CH649218A5/it not_active IP Right Cessation
- 1982-01-05 JP JP57000842A patent/JPS57136516A/ja active Granted
- 1982-01-06 NL NL8200022A patent/NL8200022A/nl not_active Application Discontinuation
- 1982-01-06 FR FR8200094A patent/FR2497510B1/fr not_active Expired
- 1982-01-06 LU LU83869A patent/LU83869A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
DE3200016C2 (it) | 1992-12-03 |
GB2091101B (en) | 1985-02-20 |
FR2497510B1 (fr) | 1986-04-25 |
US4382092A (en) | 1983-05-03 |
SE453569B (sv) | 1988-02-15 |
JPS57136516A (en) | 1982-08-23 |
BE891639A (fr) | 1982-04-16 |
AU548787B2 (en) | 1986-01-02 |
FR2497510A1 (fr) | 1982-07-09 |
JPH0424325B2 (it) | 1992-04-24 |
AU7908781A (en) | 1982-07-15 |
IT1198434B (it) | 1988-12-21 |
DE3200016A1 (de) | 1982-08-12 |
IE813099L (en) | 1982-07-06 |
SE8200007L (sv) | 1982-07-07 |
IT8147518A0 (it) | 1981-01-06 |
GB2091101A (en) | 1982-07-28 |
LU83869A1 (fr) | 1982-05-07 |
CH649218A5 (it) | 1985-05-15 |
GR75132B (it) | 1984-07-13 |
IL64632A0 (en) | 1982-03-31 |
IE52404B1 (en) | 1987-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10111849B2 (en) | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II | |
NL8200022A (nl) | Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen. | |
US4255449A (en) | Method of treating abnormal lipoprote in ratios | |
JPH027572B2 (it) | ||
CN1679532A (zh) | 治疗和饮食组合物 | |
JPH0733655A (ja) | 医薬組成物 | |
EP0336851A1 (fr) | Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique | |
US5645852A (en) | Butyric ester cyto-differtiating agents | |
US7666909B2 (en) | Enhancement of alcohol metabolism | |
WO1991007960A1 (fr) | Compositions pharmaceutiques destinees au traitement de l'ataxie et les troubles de l'equilibre | |
RU2636616C1 (ru) | Комбинированное лекарственное средство для первичной нейропротекции | |
SK287832B6 (sk) | Use of acetyl L-carnitine in association with biotin for the treatment of patients with Type 2 insulin-resistant diabetes mellitus. | |
EP3804705A1 (en) | Pharmaceutical composition for preventing diabetes and use thereof | |
RU2387448C2 (ru) | Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии | |
KR100725263B1 (ko) | HMG-CoA 리덕타제 억제제 및 카르니틴을 포함하는 항지질혈성 복합제 | |
BE1030299B1 (fr) | Application de la 5'-méthylthioadénosine dans la préparation de médicaments ou de produits de santé anti-obésité | |
RU2095059C1 (ru) | Способ профилактики и лечения атеросклероза | |
WO2003009840A1 (en) | Composition comprising at least one lipase inhibitor and carnitine | |
JP4896531B2 (ja) | 血中CoQ10量を増加させる医薬組成物 | |
WO2023156275A1 (en) | Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor | |
JPH03115220A (ja) | 非心臓由来の不整脈防止薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
BV | The patent application has lapsed |